Santen, the top Japanese company of eye drops has inaugurated its European office in Geneva, reported by Tribune de Genève on 2 September. It is reported that the company had selected Switzerland for its stability that is indispensable for a long term project, which is to become the third largest company in the ophthalmic field worldwide, from the present 15th. Major reasons of the selection of Geneva, among other Cantons, were its professionalism and good understanding of the company’s needs.
Santen’s office in Geneva will have fifteen (15) managers at the begining, and double the number in three to five years to come.
(Note, Information from Japanese source was not available yet as of 3 September.)
Point of interest: Santen had a long-term strategy in mind.
Facts aout Santen
- Established in Osaka in 1890
- Revenue (March 2015) — US$ 1,419.2 Million
- Products — Eye drops for a variety of eye diseases, including glaucoma and dry eye, supported by research and development, production and quality compliance, and sales and marketing
- The number of employees — About 3200 worldwide
The company web site –> http://www.santen.eu/eu/Pages/default.aspx